Assessment of the in-use stability of the PRRS virus of two different commercial PRRS MLV after reconstitution with PPV and SE vaccines

Home Knowledge Assessment of the in-use stability of the PRRS virus of two different commercial PRRS MLV after reconstitution with PPV and SE vaccines

Assessment of the in-use stability of the PRRS virus of two different commercial PRRS MLV after reconstitution with PPV and SE vaccines

The purpose of this study was to assess the in-use stability of the UNISTRAIN® PRRS vaccine after it has been reconstituted with ERYSENG® PARVO in comparison with the in-use stability of another European commercial PRRS MLV reconstituted with the SE and PPV vaccine from the same manufacturer.

About this article

Appeared in

IPVS & ESPHM Congress, 2016

Authors

Miranda, J.; Camprodon, A.; Fenech, M.;

Summary

One of the most important factors for obtaining registration for the combined use of a MLV PRRS vaccine and SE and PPV vaccine is to ensure that the PRRS virus is kept alive after the vaccines are mixed together. The results of the study demonstrated that the viability of the PRRS virus after mixing UNISTRAIN® PRRS and ERYSENG® PARVO can be guaranteed for 2 hours after reconstitution, unlike the non-registered combination of the other commercial MLV combined with the SE and PPV vaccine from the same manufacturer.

Share this on